Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 22 December 2000:
Vol. 290. no. 5500, pp. 2303 - 2304
DOI: 10.1126/science.290.5500.2303
Prev | Table of Contents | Next

Reports

Linkage of Plasma Abeta 42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease Pedigrees

Nilufer Ertekin-Taner,1 Neill Graff-Radford,1 Linda H. Younkin,1 Christopher Eckman,1 Matthew Baker,1 Jennifer Adamson,1 James Ronald,1 John Blangero,2 Michael Hutton,1* Steven G. Younkin1

Plasma Abeta 42 (amyloid beta 42 peptide) is invariably elevated in early-onset familial Alzheimer's disease (AD), and it is also increased in the first-degree relatives of patients with typical late-onset AD (LOAD). To detect LOAD loci that increase Abeta 42, we used plasma Abeta 42 as a surrogate trait and performed linkage analysis on extended AD pedigrees identified through a LOAD patient with extremely high plasma Abeta . Here, we report linkage to chromosome 10 with a maximal lod score of 3.93 at 81 centimorgans close to D10S1225. Remarkably, linkage to the same region was obtained independently in a genome-wide screen of LOAD sibling pairs. These results provide strong evidence for a novel LOAD locus on chromosome 10 that acts to increase Abeta .

1 Mayo Clinic Jacksonville, Jacksonville, FL 32224, USA.
2 Southwest Foundation for Biomedical Research, San Antonio, TX 78245, USA.
*   To whom correspondence should be addressed. E-mail: hutton.michael{at}mayo.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Specific Enzyme-Linked Immunosorbent Assay for Measuring {beta}-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease.
W. Xia, T. Yang, G. Shankar, I. M. Smith, Y. Shen, D. M. Walsh, and D. J. Selkoe (2009)
Arch Neurol 66, 190-199
   Abstract »    Full Text »    PDF »
Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: Implication of Additional Loci.
J. H. Lee, R. Cheng, N. Graff-Radford, T. Foroud, R. Mayeux, and for the National Institute on Aging Late-Onset Alz (2008)
Arch Neurol 65, 1518-1526
   Abstract »    Full Text »    PDF »
Molecular basis for the thiol sensitivity of insulin-degrading enzyme.
M. Neant-Fery, R. D. Garcia-Ordonez, T. P. Logan, D. J. Selkoe, L. Li, L. Reinstatler, and M. A. Leissring (2008)
PNAS 105, 9582-9587
   Abstract »    Full Text »    PDF »
Plasma amyloid {beta} protein is elevated in late-onset Alzheimer disease families.
N. Ertekin-Taner, L. H. Younkin, D. M. Yager, F. Parfitt, M. C. Baker, S. Asthana, M. L. Hutton, S. G. Younkin, and N. R. Graff-Radford (2008)
Neurology 70, 596-606
   Abstract »    Full Text »    PDF »
Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.
A. Miyashita, H. Arai, T. Asada, M. Imagawa, E. Matsubara, M. Shoji, S. Higuchi, K. Urakami, A. Kakita, H. Takahashi, et al. (2007)
Hum. Mol. Genet. 16, 2854-2869
   Abstract »    Full Text »    PDF »
Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease.
M. L. Hamshere, P. A. Holmans, D. Avramopoulos, S. S. Bassett, D. Blacker, L. Bertram, H. Wiener, N. Rochberg, R. E. Tanzi, A. Myers, et al. (2007)
Hum. Mol. Genet. 16, 2703-2712
   Abstract »    Full Text »    PDF »
Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.
S. Vepsalainen, M. Parkinson, S. Helisalmi, A. Mannermaa, H. Soininen, R. E Tanzi, L. Bertram, and M. Hiltunen (2007)
J. Med. Genet. 44, 606-608
   Abstract »    Full Text »    PDF »
The Genetics of Alzheimer's Disease.
C. K. Chai (2007)
American Journal of Alzheimer's Disease and Other Dementias 22, 37-41
   Abstract »    PDF »
A review of genome mutation and Alzheimer's disease.
P. Thomas and M. Fenech (2007)
Mutagenesis 22, 15-33
   Abstract »    Full Text »    PDF »
Is {alpha}-T catenin (VR22) an Alzheimer's disease risk gene?.
L. Bertram, K. Mullin, M. Parkinson, M. Hsiao, T. J Moscarillo, S. L Wagner, K D. Becker, G. Velicelebi, D. Blacker, and R. E Tanzi (2007)
J. Med. Genet. 44, e63
   Abstract »    Full Text »    PDF »
LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
J. Majercak, W. J. Ray, A. Espeseth, A. Simon, X.-P. Shi, C. Wolffe, K. Getty, S. Marine, E. Stec, M. Ferrer, et al. (2006)
PNAS 103, 17967-17972
   Abstract »    Full Text »    PDF »
Expanded Genomewide Scan Implicates a Novel Locus at 3q28 Among Caribbean Hispanics With Familial Alzheimer Disease.
J. H. Lee, R. Cheng, V. Santana, J. Williamson, R. Lantigua, M. Medrano, A. Arriaga, Y. Stern, B. Tycko, E. Rogaeva, et al. (2006)
Arch Neurol 63, 1591-1598
   Abstract »    Full Text »    PDF »
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
M. Riemenschneider, L. Konta, P. Friedrich, S. Schwarz, K. Taddei, F. Neff, A. Padovani, H. Kolsch, S. M. Laws, N. Klopp, et al. (2006)
Hum. Mol. Genet. 15, 2446-2456
   Abstract »    Full Text »    PDF »
Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
R. Kuwano, A. Miyashita, H. Arai, T. Asada, M. Imagawa, M. Shoji, S. Higuchi, K. Urakami, A. Kakita, H. Takahashi, et al. (2006)
Hum. Mol. Genet. 15, 2170-2182
   Abstract »    Full Text »    PDF »
Brain estrogen deficiency accelerates A{beta} plaque formation in an Alzheimer's disease animal model.
X. Yue, M. Lu, T. Lancaster, P. Cao, S.-I. Honda, M. Staufenbiel, N. Harada, Z. Zhong, Y. Shen, and R. Li (2005)
PNAS 102, 19198-19203
   Abstract »    Full Text »    PDF »
Interaction between the {alpha}-T catenin gene (VR22) and APOE in Alzheimer's disease.
E R Martin, P G Bronson, Y-J Li, N Wall, R-H Chung, D E Schmechel, G Small, P-T Xu, J Bartlett, N Schnetz-Boutaud, et al. (2005)
J. Med. Genet. 42, 787-792
   Abstract »    Full Text »    PDF »
Mutation of Active Site Residues of Insulin-degrading Enzyme Alters Allosteric Interactions.
E. S. Song, A. Daily, M. G. Fried, M. A. Juliano, L. Juliano, and L. B. Hersh (2005)
J. Biol. Chem. 280, 17701-17706
   Abstract »    Full Text »    PDF »
Elevated amyloid {beta} protein (A{beta}42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.
N. Ertekin-Taner, J. Ronald, L. Feuk, J. Prince, M. Tucker, L. Younkin, M. Hella, S. Jain, A. Hackett, L. Scanlin, et al. (2005)
Hum. Mol. Genet. 14, 447-460
   Abstract »    Full Text »    PDF »
ATP Effects on Insulin-degrading Enzyme Are Mediated Primarily through Its Triphosphate Moiety.
E. S. Song, M. A. Juliano, L. Juliano, M. G. Fried, S. L. Wagner, and L. B. Hersh (2004)
J. Biol. Chem. 279, 54216-54220
   Abstract »    Full Text »    PDF »
Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention.
L. Zhao, B. Teter, T. Morihara, G. P. Lim, S. S. Ambegaokar, O. J. Ubeda, S. A. Frautschy, and G. M. Cole (2004)
J. Neurosci. 24, 11120-11126
   Abstract »    Full Text »    PDF »
Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression.
J. Krezowski, D. Knudson, C. Ebeling, R. Pitstick, R. K. Giri, D. Schenk, D. Westaway, L. Younkin, S. G. Younkin, K. H. Ashe, et al. (2004)
Hum. Mol. Genet. 13, 1989-1997
   Abstract »    Full Text »    PDF »
Insulin-degrading enzyme and Alzheimer disease: A genetic association study in the Han Chinese.
L. Bian, J. D. Yang, T. W. Guo, Y. Sun, S. W. Duan, W. Y. Chen, Y. X. Pan, G. Y. Feng, and L. He (2004)
Neurology 63, 241-245
   Abstract »    Full Text »    PDF »
Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
K. Sleegers, G. Roks, J. Theuns, Y. S. Aulchenko, R. Rademakers, M. Cruts, W. A. van Gool, C. Van Broeckhoven, P. Heutink, B. A. Oostra, et al. (2004)
Brain 127, 1641-1649
   Abstract »    Full Text »    PDF »
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function.
Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. A. Evans, and D. A. Bennett (2004)
Arch Neurol 61, 661-666
   Abstract »    Full Text »    PDF »
Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid {beta}-Protein.
W. Farris, S. Mansourian, M. A. Leissring, E. A. Eckman, L. Bertram, C. B. Eckman, R. E. Tanzi, and D. J. Selkoe (2004)
Am. J. Pathol. 164, 1425-1434
   Abstract »    Full Text »    PDF »
Substrate Activation of Insulin-degrading Enzyme (Insulysin): A POTENTIAL TARGET FOR DRUG DEVELOPMENT.
E.-S. Song, M. A. Juliano, L. Juliano, and L. B. Hersh (2003)
J. Biol. Chem. 278, 49789-49794
   Abstract »    Full Text »    PDF »
Normal Genetic Variation, Cognition, and Aging.
P. M. Greenwood and R. Parasuraman (2003)
Behav Cogn Neurosci Rev 2, 278-306
   Abstract »    PDF »
Fine mapping of the {alpha}-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.
N. Ertekin-Taner, J. Ronald, H. Asahara, L. Younkin, M. Hella, S. Jain, E. Gnida, S. Younkin, D. Fadale, Y. Ohyagi, et al. (2003)
Hum. Mol. Genet. 12, 3133-3143
   Abstract »    Full Text »    PDF »
Genetic background regulates {beta}-amyloid precursor protein processing and {beta}-amyloid deposition in the mouse.
E. J.H. Lehman, L. S. Kulnane, Y. Gao, M. C. Petriello, K. M. Pimpis, L. Younkin, G. Dolios, R. Wang, S. G. Younkin, and B. T. Lamb (2003)
Hum. Mol. Genet. 12, 2949-2956
   Abstract »    Full Text »    PDF »
Plasma A{beta}40 and A{beta}42 and Alzheimer's disease: Relation to age, mortality, and risk.
R. Mayeux, L. S. Honig, M.-X. Tang, J. Manly, Y. Stern, N. Schupf, and P. D. Mehta (2003)
Neurology 61, 1185-1190
   Abstract »    Full Text »    PDF »
The Genetics of Adult-Onset Neuropsychiatric Disease: Complexities and Conundra?.
J. L. Kennedy, L. A. Farrer, N. C. Andreasen, R. Mayeux, and P. St George-Hyslop (2003)
Science 302, 822-826
   Abstract »    Full Text »    PDF »
Detangling Alzheimer's Disease.
L. Helmuth (2003)
Sci. Aging Knowl. Environ. 2003, oa2-2
   Abstract »    Full Text »    PDF »
Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.
N. Pankratz, W. C. Nichols, S. K. Uniacke, C. Halter, J. Murrell, A. Rudolph, C. W. Shults, P. M. Conneally, T. Foroud, and the Parkinson Study Group (2003)
Hum. Mol. Genet. 12, 2599-2608
   Abstract »    Full Text »    PDF »
Alzheimer's disease-affected brain: Presence of oligomeric A{beta} ligands (ADDLs) suggests a molecular basis for reversible memory loss.
Y. Gong, L. Chang, K. L. Viola, P. N. Lacor, M. P Lambert, C. E. Finch, G. A. Krafft, and W. L. Klein (2003)
PNAS 100, 10417-10422
   Abstract »    Full Text »    PDF »
An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures.
R. G. Bennett, F. G. Hamel, and W. C. Duckworth (2003)
Diabetes 52, 2315-2320
   Abstract »    Full Text »    PDF »
Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid {beta}-Protein Levels.
H. Fukumoto, M. Tennis, J. J. Locascio, B. T. Hyman, J. H. Growdon, and M. C. Irizarry (2003)
Arch Neurol 60, 958-964
   Abstract »    Full Text »    PDF »
Insulin and Alzheimer's disease: An amyloid connection.
D. Galasko (2003)
Neurology 60, 1886-1887
   Full Text »    PDF »
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta -protein, and the beta -amyloid precursor protein intracellular domain in vivo.
W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E. A. Eckman, M. P. Frosch, C. B. Eckman, R. E. Tanzi, D. J. Selkoe, and S. Guenette (2003)
PNAS 100, 4162-4167
   Abstract »    Full Text »    PDF »
Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community.
L. A. Farrer, A. Bowirrat, R. P. Friedland, K. Waraska, A. D. Korczyn, and C. T. Baldwin (2003)
Hum. Mol. Genet. 12, 415-422
   Abstract »    Full Text »    PDF »
Results of a high-resolution genome screen of 437 Alzheimer's Disease families.
D. Blacker, L. Bertram, A. J. Saunders, T. J. Moscarillo, M. S. Albert, H. Wiener, R. T. Perry, J. S. Collins, L. E. Harrell, R. C.P. Go, et al. (2003)
Hum. Mol. Genet. 12, 23-32
   Abstract »    Full Text »    PDF »
Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-{epsilon}4 Allele.
D. G. Cook, J. B. Leverenz, P. J. McMillan, J. J. Kulstad, S. Ericksen, R. A. Roth, G. D. Schellenberg, L.-W. Jin, K. S. Kovacina, and S. Craft (2003)
Am. J. Pathol. 162, 313-319
   Abstract »    Full Text »    PDF »
Methionine 35 Oxidation Reduces Fibril Assembly of the Amyloid Abeta -(1-42) Peptide of Alzheimer's Disease.
L. Hou, I. Kang, R. E. Marchant, and M. G. Zagorski (2002)
J. Biol. Chem. 277, 40173-40176
   Abstract »    Full Text »    PDF »
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease.
Y.-H. Suh and F. Checler (2002)
Pharmacol. Rev. 54, 469-525
   Abstract »    Full Text »    PDF »
Psychotic genes or forgetful ones?.
S. Lovestone and J. Hardy (2002)
Neurology 59, 11-12
   Full Text »    PDF »
Can we afford to develop treatments for dementia?.
S Lovestone (2002)
J. Neurol. Neurosurg. Psychiatry 72, 685
   Full Text »    PDF »
The JNK/c-Jun cascade and Alzheimer's disease.
H. Okazawa and S. Estus (2002)
American Journal of Alzheimer's Disease and Other Dementias 17, 79-88
   Abstract »    PDF »
Protein aggregates and dementia: is there a common toxicity?.
S Lovestone and D M McLoughlin (2002)
J. Neurol. Neurosurg. Psychiatry 72, 152-161
   Abstract »    Full Text »    PDF »
Genotype and phenotype in Alzheimer's disease.
C. HOLMES (2002)
The British Journal of Psychiatry 180, 131-134
   Abstract »    Full Text »    PDF »
Familial Alzheimer Disease Among Caribbean Hispanics: A Reexamination of Its Association With APOE.
S. N. Romas, V. Santana, J. Williamson, A. Ciappa, J. H. Lee, H. Z. Rondon, P. Estevez, R. Lantigua, M. Medrano, M. Torres, et al. (2002)
Arch Neurol 59, 87-91
   Abstract »    Full Text »    PDF »
Ethical Principles and Pitfalls of Genetic Testing for Dementia.
P. Hedera (2001)
J Geriatr Psychiatry Neurol 14, 213-221
   Abstract »    PDF »
Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland.
M. Hiltunen, A. Mannermaa, D. Thompson, D. Easton, M. Pirskanen, S. Helisalmi, A. M. Koivisto, M. Lehtovirta, M. Ryynanen, and H. Soininen (2001)
Neurology 57, 1663-1668
   Abstract »    Full Text »    PDF »
Detangling Alzheimer's Disease.
L. Helmuth (2001)
Sci. Aging Knowl. Environ. 2001, oa2-2
   Abstract »    Full Text »    PDF »
Public Attitudes About Genetic Testing For Alzheimer's Disease.
P. J. Neumann, J. K. Hammitt, C. Mueller, H. M. Fillit, J. Hill, N. A. Tetteh, and K. S. Kosik (2001)
Health Aff. 20, 252-264
   Abstract »    Full Text »    PDF »
Disease Mechanisms in Neuroscience.
(2001)
Neuroscientist 7, 190-191
   PDF »
Accumulation of Amyloid {beta}-Protein in the Low-Density Membrane Domain Accurately Reflects the Extent of {beta}-Amyloid Deposition in the Brain.
N. Oshima, M. Morishima-Kawashima, H. Yamaguchi, M. Yoshimura, S. Sugihara, K. Khan, D. Games, D. Schenk, and Y. Ihara (2001)
Am. J. Pathol. 158, 2209-2218
   Abstract »    Full Text »    PDF »
Chemical Andropause and Amyloid-{beta} Peptide.
S. Gandy, O. P. Almeida, J. Fonte, D. Lim, A. Waterrus, N. Spry, L. Flicker, and R. N. Martins (2001)
JAMA 285, 2195-2196
   Full Text »    PDF »
Gene on Chromosome 10 Affecting Amyloid-{beta} Is Linked to Late-Onset AD.
(2001)
Journal Watch Psychiatry 2001, 12
   Full Text »
Gene on Chromosome 10 Affecting Amyloid-{beta} Is Linked to Late-Onset AD.
(2001)
Journal Watch (General) 2001, 2
   Full Text »
Susceptibility Locus for Alzheimer's Disease on Chromosome 10.
A. Myers, P. Holmans, H. Marshall, J. Kwon, D. Meyer, D. Ramic, S. Shears, J. Booth, F. W. DeVrieze, R. Crook, et al. (2000)
Science 290, 2304-2305
   Abstract »    Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)